Lack of suppression of glucagon during OGTT contributes to the reduced incretin effect in type 2 diabetes

被引：0
|
作者：
Knop, F. K.
Vilsboll, T.
Madsbad, S.
Holst, J. J.
Krarup, T.
机构：
[1] Univ Copenhagen, Dept Intenal Med F, Copenhagen, Denmark
[2] Univ Copenhagen, Dept Med Physiol, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Endocrinol, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2006年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0663
引用
收藏
页码：403 / 403
页数：1
相关论文
共 50 条
  • [21] Abnormal incretin response in subjects with type 1 diabetes by 2-hour OGTT criteria but with normal fasting glycemia
    Prigeon, RL
    D'Alessio, TA
    Greenbaum, CJ
    [J]. DIABETES, 2001, 50 : A520 - A520
  • [22] Incretin Effect and Glucagon Responses to Oral and Intravenous Glucose in Patients With Maturity-Onset Diabetes of the Young-Type 2 and Type 3
    Ostoft, Signe H.
    Bagger, Jonatan I.
    Hansen, Torben
    Pedersen, Oluf
    Holst, Jens J.
    Knop, Filip K.
    Vilsboll, Tina
    [J]. DIABETES, 2014, 63 (08) : 2838 - 2844
  • [23] Preserved glucagon-like peptide-1 responses to oral glucose, but reduced incretin effect, insulin secretion and sensitivity in young Asians with type 2 diabetes mellitus
    Yeow, Toh Peng
    Pacini, Giovanni
    Tura, Andrea
    Hor, Chee Peng
    Lim, Shueh Lin
    Tan, Florence Hui Sieng
    Tong, Chin Voon
    Hong, Janet Yeow Hua
    Zain, Fuziah Md
    Holst, Jens Juul
    Mohamud, Wan Nazaimoon Wan
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2017, 5 (01)
  • [24] Pharmacogenetic aspects of the treatment of Type 2 diabetes with the incretin effect enhancers
    Tkac, Ivan
    Gotthardova, Ivana
    [J]. PHARMACOGENOMICS, 2016, 17 (07) : 795 - 804
  • [25] Metabolic inflexibility in type 2 diabetes is supported by untargeted metabolomics during OGTT
    Fanni, G.
    Eriksson, J. W.
    Pereira, M. J.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S267 - S267
  • [26] Emerging incretin (glucagon-like peptide-1)-derived therapies for type 2 diabetes
    Garber, Alan J.
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 : 1 - 1
  • [27] Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity
    Opinto, Giuseppina
    Natalicchio, Annalisa
    Marchetti, Piero
    [J]. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2013, 119 (04) : 170 - 178
  • [28] Effect of ameliorating glucotoxicity on incretin secretion in patients with type 2 diabetes
    Ko, S. -H.
    Lee, S. -H.
    Yoon, K. -H.
    Ahn, Y. -B.
    [J]. DIABETOLOGIA, 2010, 53
  • [29] Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes Mellitus
    Bagger, Jonatan O.
    Knop, Filip K.
    Lund, Asger
    Vestergaard, Henrik
    Holst, Jens J.
    Vilsboll, Tina
    [J]. DIABETES, 2009, 58 : A369 - A369
  • [30] Linagliptin Increases Incretin Levels, Lowers Glucagon, and Improves Glycemic Control in Type 2 Diabetes Mellitus
    Thomas Rauch
    Ulrike Graefe-Mody
    Carolyn F. Deacon
    Arne Ring
    Jens J. Holst
    Hans-Juergen Woerle
    Klaus A. Dugi
    Tim Heise
    [J]. Diabetes Therapy, 2012, 3 (1)
12345